Ferozsons Group was established in 1894 by Maulvi Ferozuddin Khan who first founded the Ferozsons publishing house. The group’s corporate vision articulated by our founder involved playing a meaningful role in the education and health of the underprivileged population of the sub-continent.
Ferozsons Laboratories Limited was thus established in 1956 as one of the first pharmaceutical companies of Pakistan, serving the cause of health and well-being for over 6 decades now in Pakistan and a growing number of international markets.
In 1960, Ferozsons became the first Pakistani pharmaceutical company to be listed on the Karachi Stock Exchange. We have a consistent track record of financial performance, and are a 6-time recipient of the Karachi Stock Exchange's 'KSE Top 25 Companies Award.' Ferozsons Group led by Ferozsons Laboratories Limited includes subsidiaries BF Biosciences Limited and Farmacia. Ferozsons Laboratories Limited, through a range of branded generics and in-licensed products has attained market leadership in the areas of cardiology, gastroenterology, hepatology, oncology, dermatology and anti-infective treatments and is promising to expand to other key areas.
Ferozsons Labs is also a leading exporter of medicines to markets in Asia and Africa, and we are actively seeking export opportunities in other markets. Ferozsons is the Pakistan marketing and distribution partner for the Boston Scientific Corporation, USA for its range of cardiac and peripheral products and interventional devices. This partnership will allow us to further strengthen our channels in cardiology, oncology, and G.I. fields. We offer principals an excellent manufacturing, marketing and distribution platform for launching their products in the Pakistan market.
Ferozsons Laboratories Limited has a fully cGMP compliant production facility in Nowshera which is ISO 9001 certified and we are fully equipped with state of the art manufacturing and testing equipment. The facility consists of independent sections, each with its own dedicated air handling system to avoid cross-contamination between different classes of drugs being manufactured. Our production capabilities include the manufacturing of tablets, capsules, syrups, suspensions, creams and ointments. Our facility control laboratory is among the best equipped in the industry and possesses Malver Particle Size Analyzers, High Performance Liquid Chromatographs (HPLC), Gas Chromatograph (GC), Fourier Transfer-IR Spectrophotometer and UV-Visible spectrometers, in addition to dissolution, disintegration, hardness and friability testers.
In 2012, the Company undertook a major expansion in its manufacturing, adding a new production wing for the production of solid dosage forms. The new wing is now operational. Ferozsons with a 60 year history continues to serve patients in Pakistan with breakthrough technologies, treatments and interventions.